Scrying Biotech
Long only, biotech, micro-cap, small-cap

Sunshine Heart: An Elementary Question Reveals A Profound Problem

I'm a long-term investor and short-term trader of stocks. I don't buy or sell options, but were I too, I wouldn't hesitate to short Sunshine Heart (SSH) at this time. The reason for this is simple: trial enrollment numbers for 2013 in the pivotal phase 3 Counter-HF trial were abysmal.

I don't want to lose money or have funds tied up in a company whose trial completion date might extend outward like the Emerald City on the road to the Wizard of Oz.

If you want to find out how terrific of a device this is, I want you to read a series of articles by Robert Honeywell right here on Seeking Alpha that address its enormous market...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
WITH SEEKING ALPHA PRO, INVESTORS CAN ALSO:
  • Access Top Ideas, chosen by Seeking Alpha’s editors
  • Filter long and short ideas by market cap and sector
  • Get Coverage of over 5,000 stocks, many of which have little or no coverage elsewhere
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO." Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else." Patrick Rice, Mainstay Capital Management
100% Satisfaction Guaranteed
Money back guarantee. Seeking Alpha PRO members receive a no-questions-asked refund for membership on months paid and not used. Details